Penserra Capital Management LLC X Biotech Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$10.95 - $16.07 $7,610 - $11,168	-695 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.95 - $18.24 $129 - $182	10 Added 1.46%	695 $9,000
Q2 2021 Aug 12, 2021	BUY	$15.83 - $17.84 $316 - $356	20 Added 3.01%	685 $11,000
Q1 2021 May 13, 2021	SELL	$15.92 - $20.3 $79 - $101	-5 Reduced 0.75%	665 $11,000
Q4 2020 Feb 12, 2021	BUY	$15.65 - $19.92 $6,604 - $8,406	422 Added 170.16%	670 $10,000
Q3 2020 Nov 13, 2020	BUY	$13.97 - $21.16 $3,464 - $5,247	248 New	248 $4,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.